Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
Aja Beckett quit her job after her weight-loss shot-tracking app, Shotsy, took off on Reddit.
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results